The Discounted Cash Flow (DCF) valuation of Oyster Point Pharma Inc (OYST) is (922.94) USD. With the latest stock price at 11.17 USD, the upside of Oyster Point Pharma Inc based on DCF is -8362.6%.
Based on the latest price of 11.17 USD and our DCF valuation, Oyster Point Pharma Inc (OYST) is a sell. selling OYST stocks now will result in a potential gain of 8362.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.3% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (2,388.57) - (578.90) | (922.94) |
| Upside | -21483.8% - -5282.7% | -8362.6% |